Carcinoembryonic Antigen Market size worth $2.78bn by 2023

1
Carcinoembryonic Antigen (CEA) Market Size worth
2.78bn by 2023 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Carcinoembryonic Antigen
Market

• Global carcinoembryonic antigen (CEA) market size
  was USD 1.67 billion in 2015, with 6.6 CAGR
  growth forecast from 2016 to 2023.
• North America, with U.S. carcinoembryonic antigen
  market size accounting for over 78 regional
  revenue in 2015, will be driven due to high
  incidence rates of cancers, presence of
  sophisticated healthcare infrastructure, and high
  patient awareness levels.
• Europe CEA market, with Germany, France Spain
  occupying over 45 share, will see 6.9 CAGR from
  2016 to 2023.  
• Breast cancer carcinoembryonic antigen market
  share is forecast to exceed USD 460 million in
  revenue by 2023. Breast cancer market is
  stimulated by factors such as growing number of
  female population above 50 years, rising demand
  for Hormone Replacement Therapy (HRT), and
  cosmetic surgeries.

3
Continued...

• Technological advancements in proteomics, such as
  protein labeling, mass spectrometry, protein
  array, protein bioinformatics, and novel
  immunological assays such as radioimmunoassay is
  responsible for significant rise in the demand
  for CEA test used in combination.
• Industry rivalry for the global carcinoembryonic
  antigen market share is expected to be moderately
  high, since the manufacturers need to deal with
  cut throat price competition in the market, and
  are required to incessantly launch new and
  technologically advanced products. Acquisitions
  and mergers are one of the major strategies
  adopted by industry participants.

4
North America carcinoembryonic antigen market
size, by application, 2014-2023 (USD Million)

5

Browse Full Market Research Report On
Carcinoembryonic Antigen Market _at_
http//goo.gl/mhwybn Request for a Sample of
this Research Report _at_ https//www.gminsights.com/
request-sample/detail/427 https//www.gminsights.
com/request-sample/detail/49
6
360 Analysis

• Application Analysis
• Colorectal cancer is the predominant market
  segment in 2016, with 42 of the global
  carcinoembryonic antigen market share, owing to a
  significantly large patient pool becoming prone
  to cancer due to consumption of fatty foods,
  alcohol, and exposure to carcinogenic elements.
• Regional Analysis
• North America, driven by the U.S CEA market size,
  is targeted to exceed USD 800 million in 2016,
  making it the largest regional market. Increased
  awareness level to detect the cancer at early
  stages, followed by improved health care
  facilities for cancer therapeutics will stimulate
  growth.
• Competitive Market Share
• The top players in this market include Roche
  Diagnostics, Quest Diagnostics, Abbott
  Diagnostics, and GenWay Biotech, Inc. among
  others. New product launch in response to growing
  demand for minimally invasive procedures, and
  early detection methods is major strategy adopted
  by the players in this market, in order to
  maintain leadership position.

7
Stay In Touch Website www.gminsights.com Soci
al Media